S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › BIM › Research report
← BIM page
XStocksXray
Market X-Ray report · 19 October 2026

BIMobject AB (BIM)

Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026

Key indicators

Last closeSEK 4.995
52-week range3.810 – 5.950
Return, 1 month / 3 months−0.9% / +3.2%
Return, 1 year / 3 years−12.7% / +74.0%
TrendUptrend
RSI (14)60
Volatility (1 year)42.1%
Worst drawdown (1 year)-32.7%
Average daily value traded0.48M SEK
Dividend yield–

Market X-Ray price-based

62/ 100 · High confidence · ahead of 67% of stocks on this exchange
Trend71
Momentum60
Stability (higher is calmer)62
Liquidity50
Income–

Five-year price chart navy: price · brown: 200-day average

1.583.295.006.718.422021-102023-012024-042025-072026-10

About the company

BIMobject operates a digital platform for building information modelling content, where manufacturers of building products publish detailed digital models of their goods. Architects, engineers and construction professionals use the service to find and download these models for their design work. The company is based in Sweden and serves customers across the construction and property industries, connecting product makers with the people who specify building materials.

The shares are listed on the Stockholm Exchange in Sweden under the code BIM, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

BIMobject AB (BIM) trades on the Stockholm Exchange in Sweden. It last closed at SEK 4.995 on 19 October 2026.

Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 301 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 12.7% and over the last three months it rose 3.2%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
BIMobject AB (BIM)

The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange

Lens and metricValueScoreReading
Trend71 · StrongTrading above its long-term averages and near its highs.
Above 200-day average5.7%
From 52-week high-15.1%
Momentum60 · FairTypical recent returns for this exchange.
3-month return3.2%
6-month return3.0%
12-month return, skipping the last month-11.9%
Stability (higher is calmer)62 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)42.1%
Worst drawdown, 1 year (smaller is calmer)-32.7%
Liquidity50 · FairModerate trading activity.
Average daily value traded0.48M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.

Weak spots

No lens is weak against its exchange.

Returns

1 week+6.5%
1 month−0.9%
3 months+3.2%
6 months+3.0%
1 year−12.7%
3 years+74.0%
5 years–

Signals

50-day / 200-day average4.879 / 4.727
Golden / death cross (60 days)Golden, 57 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.244

Technical summary

DailyStrongly bullish11 bullish · 3 neutral · 2 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026